Subjects: DENSITOMETRIA ÓSSEA, TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS, MENOPAUSA(EFEITOS DE DROGAS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASSABKI, J. O. P. et al. Evaluation of bone mineral densitometry (BMD) in menopaused women taking oral alendronate compared with hormonal replacement therapy (HRT) in low doses. 2002, Anais.. Chicago: Faculdade de Medicina, Universidade de São Paulo, 2002. . Acesso em: 06 nov. 2024.APA
Massabki, J. O. P., Fonseca, A. M., Bagnoli, V. R., Chnee, L. H., & Penteado, S. R. L. (2002). Evaluation of bone mineral densitometry (BMD) in menopaused women taking oral alendronate compared with hormonal replacement therapy (HRT) in low doses. In . Chicago: Faculdade de Medicina, Universidade de São Paulo.NLM
Massabki JOP, Fonseca AM, Bagnoli VR, Chnee LH, Penteado SRL. Evaluation of bone mineral densitometry (BMD) in menopaused women taking oral alendronate compared with hormonal replacement therapy (HRT) in low doses. 2002 ;[citado 2024 nov. 06 ]Vancouver
Massabki JOP, Fonseca AM, Bagnoli VR, Chnee LH, Penteado SRL. Evaluation of bone mineral densitometry (BMD) in menopaused women taking oral alendronate compared with hormonal replacement therapy (HRT) in low doses. 2002 ;[citado 2024 nov. 06 ]
